Owens & Minor, Inc. (NYSE:OMI) Shares Bought by Nordea Investment Management AB

Nordea Investment Management AB raised its position in Owens & Minor, Inc. (NYSE:OMI) by 5.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 174,368 shares of the company’s stock after purchasing an additional 9,725 shares during the quarter. Nordea Investment Management AB’s holdings in Owens & Minor were worth $2,269,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. Quarry LP increased its stake in shares of Owens & Minor by 290.1% in the second quarter. Quarry LP now owns 2,099 shares of the company’s stock valued at $28,000 after purchasing an additional 1,561 shares during the period. DekaBank Deutsche Girozentrale increased its stake in shares of Owens & Minor by 76.6% during the second quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company’s stock valued at $43,000 after acquiring an additional 1,356 shares during the period. Blue Trust Inc. increased its stake in shares of Owens & Minor by 176.8% during the third quarter. Blue Trust Inc. now owns 2,787 shares of the company’s stock valued at $44,000 after acquiring an additional 1,780 shares during the period. Canada Pension Plan Investment Board acquired a new position in shares of Owens & Minor during the second quarter valued at approximately $82,000. Finally, Meeder Asset Management Inc. increased its stake in shares of Owens & Minor by 844.1% during the third quarter. Meeder Asset Management Inc. now owns 9,016 shares of the company’s stock valued at $141,000 after acquiring an additional 8,061 shares during the period. Institutional investors and hedge funds own 98.04% of the company’s stock.

Insider Buying and Selling

In related news, CFO Jonathan A. Leon sold 5,282 shares of the firm’s stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $11.82, for a total value of $62,433.24. Following the completion of the transaction, the chief financial officer now owns 130,822 shares of the company’s stock, valued at approximately $1,546,316.04. This trade represents a 3.88 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 3.59% of the company’s stock.

Owens & Minor Trading Down 3.4 %

Shares of NYSE:OMI opened at $13.92 on Friday. The stock has a market capitalization of $1.07 billion, a price-to-earnings ratio of -21.42, a PEG ratio of 0.48 and a beta of 0.46. Owens & Minor, Inc. has a 1-year low of $11.42 and a 1-year high of $28.35. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09. The company has a 50 day moving average price of $13.18 and a 200 day moving average price of $14.18.

Owens & Minor (NYSE:OMI) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The firm had revenue of $2.72 billion during the quarter, compared to analyst estimates of $2.68 billion. During the same quarter last year, the business posted $0.44 EPS. The company’s revenue was up 5.0% on a year-over-year basis. On average, research analysts anticipate that Owens & Minor, Inc. will post 1.49 EPS for the current fiscal year.

Wall Street Analyst Weigh In

OMI has been the topic of a number of research analyst reports. Barclays lowered their price objective on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 5th. UBS Group lowered their price objective on shares of Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a research note on Tuesday, November 5th. Citigroup lowered their price objective on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research note on Tuesday, November 5th. Finally, Robert W. Baird lowered their price objective on shares of Owens & Minor from $19.00 to $14.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 5th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $18.50.

Owens & Minor Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.